Asthma is a widespread condition that can significantly impact quality of life, and despite advances in treatment, it remains a major public health concern. Preventing asthma remains one of the greatest research challenges. An Australian team recently evaluated whether neonatal vaccination with Bacillus Calmette-Guérin (BCG)—a vaccine developed for tuberculosis—could also serve as an immunomodulatory tool in preventing asthma and allergies.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
